THE LUMINEX LABORATORY Trademark
THE LUMINEX LABORATORY is a USPTO trademark filed by Luminex Corporation. Status: Abandoned.
Trademark Facts
| Mark | THE LUMINEX LABORATORY |
|---|---|
| Serial Number | 78150365 |
| Status | Abandoned |
| Filing Date | 2002-08-02 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 009 (Electronics & Software), 042 (Software & IT) |
| Owner | Luminex Corporation |
| Attorney of Record | Pamela S. Ratliff |
| Prosecution Events | 4 |
| Latest Event | ABN2 on 2003-08-20 |
Goods & Services
Class 001: Diagnostic reagents and microspheres for scientific or research use for conducting molecular analysis using flow microfluorimetry and/or multiemission ratiometric fluorophors for healthcare, environmental, agricultural, diagnostic, and other applications; Class 005: Diagnostic reagents and microspheres for clinical or medical use for conducting molecular analysis using flow microfluorimetry and/or multiemission ratiometric fluorophors for healthcare, environmental, agricultural, diagnostic, and other applications; Class 009: Computer software containing databases of information in the field of bioinformatics; database management and searching software for use in the field of bioinformatics; series of algorithms that generate decision rules and computer programs that apply decision rules to data; Class 042: Drug discovery services; pharmaceutical research services; pre-clinical screening, and clinical trial, research and evaluation services; bioinformatics, biosignatures, genomics, proteomics and pharmacology research services; development of human disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening, pre-clinical and pharmaceutical programs; research and development of new diagnostic products and services for others; compilation of databases for use in pharmaceutical research; compilation of databases for use in research into human gene and human protein functions; design of computer models for use in pre-clinical, clinical and pharmaceutical research; consultancy, information and advisory services for all the aforesaid services